Two Sigma Investments’s Blueprint Medicines BPMC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-12,800
Closed -$576K 3021
2023
Q1
$576K Sell
12,800
-32,909
-72% -$1.48M ﹤0.01% 2142
2022
Q4
$2M Sell
45,709
-63,526
-58% -$3.05M 0.01% 1318
2022
Q3
$7.2M Buy
109,235
+98,522
+920% +$6.33M 0.02% 616
2022
Q2
$541K Buy
+10,713
New +$628K ﹤0.01% 1796
2020
Q1
Sell
-43,318
Closed -$3.47M 3133
2019
Q4
$3.47M Sell
43,318
-75,052
-63% -$5.62M 0.01% 1190
2019
Q3
$8.7M Sell
118,370
-98,156
-45% -$8.48M 0.03% 597
2019
Q2
$20.4M Buy
216,526
+118,313
+120% +$9.77M 0.07% 345
2019
Q1
$7.86M Sell
98,213
-111,653
-53% -$8.25M 0.03% 762
2018
Q4
$11.3M Buy
209,866
+96,007
+84% +$5.84M 0.04% 505
2018
Q3
$8.89M Sell
113,859
-233,979
-67% -$16.3M 0.02% 692
2018
Q2
$22.1M Buy
347,838
+272,350
+361% +$21.7M 0.07% 380
2018
Q1
$6.92M Buy
75,488
+25,278
+50% +$2.18M 0.02% 770
2017
Q4
$3.79M Sell
50,210
-60,483
-55% -$4.26M 0.01% 1042
2017
Q3
$7.71M Buy
110,693
+47,216
+74% +$2.52M 0.03% 618
2017
Q2
$3.22M Sell
63,477
-84,628
-57% -$3.59M 0.01% 1112
2017
Q1
$5.92M Buy
+148,105
New +$5.3M 0.02% 849
2016
Q4
Sell
-9,700
Closed -$288K 3105
2016
Q3
$288K Buy
+9,700
New +$241K ﹤0.01% 2769

Other funds holding BPMC

Two Sigma Investments's BPMC Position: Q2 2023 in Review

Two Sigma Investments sold out of Blueprint Medicines (BPMC) in Q2 2023, closing a stake of 12,800 shares — an estimated $576K sold.

Two Sigma Investments first reported a position in BPMC in Q3 2016 and held it in 17 quarters. The position peaked at $22.1M in Q2 2018. 222 funds tracked by Wall St. Rank hold BPMC as of Q2 2023.

  • Two Sigma Investments reported no remaining Blueprint Medicines position as of Q2 2023 after selling out during the quarter.
  • Two Sigma Investments sold 12,800 Blueprint Medicines shares in Q2 2023, an estimated $576K.
  • Two Sigma Investments first reported a position in Blueprint Medicines in Q3 2016 and held it in 17 quarters.
  • Two Sigma Investments's Blueprint Medicines position peaked at $22.1M in Q2 2018.
  • 222 funds tracked by Wall St. Rank held Blueprint Medicines as of Q2 2023.

Based on Two Sigma Investments's 13F filing for Q2 2023, filed 14 Aug 2023.